Davita - Collinsville is a medicare approved dialysis facility center in Collinsville, Illinois and it has 8 dialysis stations. It is located in Madison county at 101 Lanter Ct., Collinsville, IL, 62234. You can reach out to the office of Davita - Collinsville at (618) 344-2016. This dialysis clinic is managed and/or owned by Davita. Davita - Collinsville has the following ownership type - Profit. It was first certified by medicare in September, 2017. The medicare id for this facility is 142822 and it accepts patients under medicare ESRD program.
| Name | Davita - Collinsville |
|---|---|
| Location | 101 Lanter Ct., Collinsville, Illinois |
| No. of Dialysis Stations | 8 |
| Medicare ID | 142822 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 101 Lanter Ct., Collinsville, Illinois, 62234 | |
| (618) 344-2016 | |
| Not Available |
News Archive
Peripheral artery disease (PAD), or blockages in the arteries outside of the heart, affects more than 200 million people worldwide and 12.5 million people in the United States. Patients with this circulatory disorder may develop severe leg pain or unhealing wounds that require a minimally invasive revascularization procedure to open the blood vessels to improve blood flow.
The first intimation of the current COVID-19 crisis came with the news of severe pneumonic illness caused by an unknown agent in a Chinese city called Wuhan, issued on the last day of 2019. Following this, researchers found the cause to be a novel coronavirus, closely related to the earlier SARS virus, now called severe acute respiratory syndrome coronavirus 2.
Today, the success of the Young Investigator Grant for Probiotics Research (YIGPRO) program was confirmed with the announcement of two $50,000 grants that are available to rising young investigators in the field of probiotics. 2010 marks the third consecutive year for the grants. The grants were established by The Global Probiotics Council (GPC), a committee formed by DANONE and Yakult Honsha Co., Ltd., and are designed to contribute to the advancement of probiotics and gastrointestinal microbiota research in the United States.
One of the major mysteries in treating patients with Covid-19 is the frequent development of blood clots that can subsequently damage their organs and sometimes be fatal.
› Verified 1 days ago
| NPI Number | 1811437106 |
| Organization Name | Collinsville Dialysis |
| Doing Business As | Total Renal Care Inc |
| Address | 101 Lanter Ct Collinsville, Illinois, 62234 |
| Phone Number | (618) 344-2016 |
News Archive
Peripheral artery disease (PAD), or blockages in the arteries outside of the heart, affects more than 200 million people worldwide and 12.5 million people in the United States. Patients with this circulatory disorder may develop severe leg pain or unhealing wounds that require a minimally invasive revascularization procedure to open the blood vessels to improve blood flow.
The first intimation of the current COVID-19 crisis came with the news of severe pneumonic illness caused by an unknown agent in a Chinese city called Wuhan, issued on the last day of 2019. Following this, researchers found the cause to be a novel coronavirus, closely related to the earlier SARS virus, now called severe acute respiratory syndrome coronavirus 2.
Today, the success of the Young Investigator Grant for Probiotics Research (YIGPRO) program was confirmed with the announcement of two $50,000 grants that are available to rising young investigators in the field of probiotics. 2010 marks the third consecutive year for the grants. The grants were established by The Global Probiotics Council (GPC), a committee formed by DANONE and Yakult Honsha Co., Ltd., and are designed to contribute to the advancement of probiotics and gastrointestinal microbiota research in the United States.
One of the major mysteries in treating patients with Covid-19 is the frequent development of blood clots that can subsequently damage their organs and sometimes be fatal.
› Verified 1 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.